Found 83 matching trials
Efficacy and Safety of Dapagliflozin in Patients with Non-alcoholic Steatohepatitis
PHASE2Patients with non-alcoholic fatty liver disease (NAFLD) are at increased ri...
Location
National Hepatology and Tropical Medicine Research Institute
Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy
NAEfficacy and safety of early administration of the SGLT-2 inhibitor dapagli...
Location
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms
PHASE2TACTIC-E is a randomised, parallel arm, open-label platform trial for inves...
Location
Cambridge University Hospitals NHS Foundation Trust
Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients
PHASE2Pre-diabetes is a state characterized by subclinical impairment in glycemic...
Location
Peking University Third Hospital
Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.
PHASE4Randomized placebo-controlled double-blind cross-over N=1 trial in adult ma...
Location
Ziekenhuisgroep Twente
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
PHASE4The primary purpose of this study is to evaluate the impact of dapagliflozi...
Location
Heart Group of the Eastern Shore
Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?
PHASE4Left ventricular hypertrophy (LVH) is common in people with type 2 diabetes...
Location
Ninewells Hospital
Assessing the Clinical Outcomes of Dapagliflozin Versus Acetazolamide in Patients With Acute Heart Failure
PHASE2This study investigates the comparative clinical outcomes of dapagliflozin,...
Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial
PHASE4Repaired Tetralogy of Fallot (rTOF) is the leading cause of congenital cyan...
Location
Department of Medicine, Queen Mary Hospital
Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy
PHASE4To assess the efficacy of treatment with sitagliptin or dapagliflozin or lo...